Block of glucocorticoid synthesis during re-activation inhibits extinction of an established fear memory

Jacqueline Blundell, Cory A. Blaiss, Diane C. Lagace, Amelia J. Eisch, Craig M. Powell

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Background: The pharmacology of traumatic memory extinction has not been fully characterized despite its potential as a therapeutic target for established, acquired anxiety disorders, including post-traumatic stress disorder (PTSD). Here we examine the role of endogenous glucocorticoids in traumatic memory extinction. Methods: Male C57BL/6J mice were injected with corticosterone (10 mg/kg, i.p.) or metyrapone (50 mg/kg, s.c.) during re-activation of a contextual fear memory, and compared to vehicle groups (N= 10-12 per group). To ensure that metyrapone was blocking corticosterone synthesis, we measured corticosterone levels following re-activation of a fear memory in metyrapone- and vehicle-treated animals. Results: Corticosterone administration following extinction trials caused a long-lasting inhibition of the original fear memory trace. In contrast, blockade of corticosteroid synthesis with metyrapone prior to extinction trials enhanced retrieval and prevented extinction of context-dependent fear responses in mice. Further behavioral analysis suggested that the metyrapone enhancement of retrieval and prevention of extinction were not due to non-specific alterations in locomotor or anxiety-like behavior. In addition, the inhibition of extinction by metyrapone was rescued by exogenous administration of corticosterone following extinction trials. Finally, we confirmed that the rise in corticosterone during re-activation of a contextual fear memory was blocked by metyrapone. Conclusions: We demonstrate that extinction of a classical contextual fear memory is dependent on endogenous glucocorticoid synthesis during re-activation of a fear memory. Our data suggest that decreased glucocorticoids during fear memory re-activation may contribute to the inability to extinguish a fear memory, thus contributing to one of the core symptoms of PTSD.

Original languageEnglish (US)
Pages (from-to)453-460
Number of pages8
JournalNeurobiology of Learning and Memory
Volume95
Issue number4
DOIs
StatePublished - May 2011

Fingerprint

Glucocorticoids
Metyrapone
Fear
Corticosterone
Post-Traumatic Stress Disorders
Psychological Extinction
Anxiety Disorders
Inbred C57BL Mouse
Adrenal Cortex Hormones
Anxiety
Pharmacology

Keywords

  • Corticosterone
  • Extinction
  • Fear conditioning
  • Glucocorticoids
  • Metyrapone
  • Post-traumatic stress disorder

ASJC Scopus subject areas

  • Behavioral Neuroscience
  • Cognitive Neuroscience
  • Experimental and Cognitive Psychology

Cite this

Block of glucocorticoid synthesis during re-activation inhibits extinction of an established fear memory. / Blundell, Jacqueline; Blaiss, Cory A.; Lagace, Diane C.; Eisch, Amelia J.; Powell, Craig M.

In: Neurobiology of Learning and Memory, Vol. 95, No. 4, 05.2011, p. 453-460.

Research output: Contribution to journalArticle

Blundell, Jacqueline ; Blaiss, Cory A. ; Lagace, Diane C. ; Eisch, Amelia J. ; Powell, Craig M. / Block of glucocorticoid synthesis during re-activation inhibits extinction of an established fear memory. In: Neurobiology of Learning and Memory. 2011 ; Vol. 95, No. 4. pp. 453-460.
@article{43cfb23b7887408abf669f2a1737d5ae,
title = "Block of glucocorticoid synthesis during re-activation inhibits extinction of an established fear memory",
abstract = "Background: The pharmacology of traumatic memory extinction has not been fully characterized despite its potential as a therapeutic target for established, acquired anxiety disorders, including post-traumatic stress disorder (PTSD). Here we examine the role of endogenous glucocorticoids in traumatic memory extinction. Methods: Male C57BL/6J mice were injected with corticosterone (10 mg/kg, i.p.) or metyrapone (50 mg/kg, s.c.) during re-activation of a contextual fear memory, and compared to vehicle groups (N= 10-12 per group). To ensure that metyrapone was blocking corticosterone synthesis, we measured corticosterone levels following re-activation of a fear memory in metyrapone- and vehicle-treated animals. Results: Corticosterone administration following extinction trials caused a long-lasting inhibition of the original fear memory trace. In contrast, blockade of corticosteroid synthesis with metyrapone prior to extinction trials enhanced retrieval and prevented extinction of context-dependent fear responses in mice. Further behavioral analysis suggested that the metyrapone enhancement of retrieval and prevention of extinction were not due to non-specific alterations in locomotor or anxiety-like behavior. In addition, the inhibition of extinction by metyrapone was rescued by exogenous administration of corticosterone following extinction trials. Finally, we confirmed that the rise in corticosterone during re-activation of a contextual fear memory was blocked by metyrapone. Conclusions: We demonstrate that extinction of a classical contextual fear memory is dependent on endogenous glucocorticoid synthesis during re-activation of a fear memory. Our data suggest that decreased glucocorticoids during fear memory re-activation may contribute to the inability to extinguish a fear memory, thus contributing to one of the core symptoms of PTSD.",
keywords = "Corticosterone, Extinction, Fear conditioning, Glucocorticoids, Metyrapone, Post-traumatic stress disorder",
author = "Jacqueline Blundell and Blaiss, {Cory A.} and Lagace, {Diane C.} and Eisch, {Amelia J.} and Powell, {Craig M.}",
year = "2011",
month = "5",
doi = "10.1016/j.nlm.2011.02.006",
language = "English (US)",
volume = "95",
pages = "453--460",
journal = "Neurobiology of Learning and Memory",
issn = "1074-7427",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - Block of glucocorticoid synthesis during re-activation inhibits extinction of an established fear memory

AU - Blundell, Jacqueline

AU - Blaiss, Cory A.

AU - Lagace, Diane C.

AU - Eisch, Amelia J.

AU - Powell, Craig M.

PY - 2011/5

Y1 - 2011/5

N2 - Background: The pharmacology of traumatic memory extinction has not been fully characterized despite its potential as a therapeutic target for established, acquired anxiety disorders, including post-traumatic stress disorder (PTSD). Here we examine the role of endogenous glucocorticoids in traumatic memory extinction. Methods: Male C57BL/6J mice were injected with corticosterone (10 mg/kg, i.p.) or metyrapone (50 mg/kg, s.c.) during re-activation of a contextual fear memory, and compared to vehicle groups (N= 10-12 per group). To ensure that metyrapone was blocking corticosterone synthesis, we measured corticosterone levels following re-activation of a fear memory in metyrapone- and vehicle-treated animals. Results: Corticosterone administration following extinction trials caused a long-lasting inhibition of the original fear memory trace. In contrast, blockade of corticosteroid synthesis with metyrapone prior to extinction trials enhanced retrieval and prevented extinction of context-dependent fear responses in mice. Further behavioral analysis suggested that the metyrapone enhancement of retrieval and prevention of extinction were not due to non-specific alterations in locomotor or anxiety-like behavior. In addition, the inhibition of extinction by metyrapone was rescued by exogenous administration of corticosterone following extinction trials. Finally, we confirmed that the rise in corticosterone during re-activation of a contextual fear memory was blocked by metyrapone. Conclusions: We demonstrate that extinction of a classical contextual fear memory is dependent on endogenous glucocorticoid synthesis during re-activation of a fear memory. Our data suggest that decreased glucocorticoids during fear memory re-activation may contribute to the inability to extinguish a fear memory, thus contributing to one of the core symptoms of PTSD.

AB - Background: The pharmacology of traumatic memory extinction has not been fully characterized despite its potential as a therapeutic target for established, acquired anxiety disorders, including post-traumatic stress disorder (PTSD). Here we examine the role of endogenous glucocorticoids in traumatic memory extinction. Methods: Male C57BL/6J mice were injected with corticosterone (10 mg/kg, i.p.) or metyrapone (50 mg/kg, s.c.) during re-activation of a contextual fear memory, and compared to vehicle groups (N= 10-12 per group). To ensure that metyrapone was blocking corticosterone synthesis, we measured corticosterone levels following re-activation of a fear memory in metyrapone- and vehicle-treated animals. Results: Corticosterone administration following extinction trials caused a long-lasting inhibition of the original fear memory trace. In contrast, blockade of corticosteroid synthesis with metyrapone prior to extinction trials enhanced retrieval and prevented extinction of context-dependent fear responses in mice. Further behavioral analysis suggested that the metyrapone enhancement of retrieval and prevention of extinction were not due to non-specific alterations in locomotor or anxiety-like behavior. In addition, the inhibition of extinction by metyrapone was rescued by exogenous administration of corticosterone following extinction trials. Finally, we confirmed that the rise in corticosterone during re-activation of a contextual fear memory was blocked by metyrapone. Conclusions: We demonstrate that extinction of a classical contextual fear memory is dependent on endogenous glucocorticoid synthesis during re-activation of a fear memory. Our data suggest that decreased glucocorticoids during fear memory re-activation may contribute to the inability to extinguish a fear memory, thus contributing to one of the core symptoms of PTSD.

KW - Corticosterone

KW - Extinction

KW - Fear conditioning

KW - Glucocorticoids

KW - Metyrapone

KW - Post-traumatic stress disorder

UR - http://www.scopus.com/inward/record.url?scp=79955464981&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955464981&partnerID=8YFLogxK

U2 - 10.1016/j.nlm.2011.02.006

DO - 10.1016/j.nlm.2011.02.006

M3 - Article

C2 - 21333745

AN - SCOPUS:79955464981

VL - 95

SP - 453

EP - 460

JO - Neurobiology of Learning and Memory

JF - Neurobiology of Learning and Memory

SN - 1074-7427

IS - 4

ER -